Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MDM4 | O15151 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | CASP3 | P42574 | 2/20 | 0.50 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29989986 | 1.00 | KMT2A (0.52) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL29591196 | 1.00 | KMT2A (0.52) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL1709129 | 1.00 | KMT2A (0.52) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL30074491 | 1.00 | KMT2A (0.52) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL5323666 | 1.00 | KMT2A (0.52) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL7423331 | 1.00 | KMT2A (0.52) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL29350883 | 1.00 | KMT2A (0.52) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL22069879 | 0.96 | PTPN1 (0.49) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL20732318 | 0.96 | PTPN1 (0.49) | KMT2AMDM4TP53PTPN1CASP3 | |
| SCHEMBL31133584 | 0.96 | PTPN1 (0.49) | KMT2AMDM4TP53PTPN1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. | 2024-12-05 | — | — | US | disclosed |
| WO-2023026994-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE-DRUG CONJUGATE | 武田薬品工業株式会社 | 2023-03-02 | — | — | WO | disclosed |
| CN-108136043-B | Protein conjugates | 诺和诺德股份有限公司 | 2022-09-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | GPR119, INSR, IAPP | KMT2A 2843/4885MDM4 1517/4885TP53 2901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.